RT Journal Article
SR Electronic
T1 Level and determinants of willingness to pay for rapid COVID-19 testing delivered through private retail pharmacies in Kenya
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.10.21264807
DO 10.1101/2021.10.10.21264807
A1 Jacob Kazungu
A1 Audrey Mumbi
A1 Precious Kilimo
A1 Jessica Vernon
A1 Edwine Barasa
A1 Peter Mugo
YR 2021
UL http://medrxiv.org/content/early/2021/10/11/2021.10.10.21264807.abstract
AB Introduction To support the government response to the coronavirus disease 2019 (COVID-19) pandemic, accessible and sustainable testing approaches are needed. Private retail pharmacies are a key channel through which communities can access COVID-19 testing. We examined the level and determinants of the willingness to pay (WTP) for rapid COVID-19 testing delivered through private retail pharmacies in Kenya.Methods Data was collected following a cross-sectional double-bounded dichotomous choice contingent valuation survey across 341 clients visiting five private retail pharmacies in Nairobi, Kisumu and Siaya counties.Results Our findings indicate mean and median WTP levels of KES 611 (US$ 5.59) and KES 506 (US$ 4.63), respectively. Estimated WTP varied across counties and increased with household income and self-reported interest in pharmacy-based COVID-19 rapid testing.Conclusion These findings can inform price setting, price differentiation, price subsidization and other program design features geared towards enhancing affordability, equity, and uptake.What is already known?The Coronavirus disease 2019 (COVID-19) global pandemic continues to cause great morbidity, mortality, social and economic burden.Pharmacies in Kenya have been involved in the delivery of several health interventions, such as malaria rapid testing, HIV self-testing, and other disease screening services.While COVID-19 testing remains an important response strategy to the ongoing COVID-19 pandemic, it is not clear how much pharmacy clients in Kenya and similar settings would be willing to pay (WTP) to obtain rapid COVID-19 testing at pharmaciesWhat are the new findings?The mean and median willingness to pay (WTP) for a rapid test delivered at a private retail pharmacy was KES 611 (US$ 5.59) and KES 506 (US$ 4.63), respectively.WTP varied by county, hence, the need for county-specific price-setting for pharmacy-based COVID-19 testing.WTP increased with household income and interest in getting the COVID-19 test at a private retail pharmacy.What do the new findings imply?A better understanding of the user’s willingness to pay price that can guide price setting, price differentiation, price subsidization and other program design features geared towards enhancing affordability, equity, and uptake.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Foundation for Innovative New Diagnostics.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We received ethical approval from the Kenya Medical Research Institute (KEMRI) Scientific and Ethics Review Unit (SERU) under SERU number SSC: 4115I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors